Company news
Alpha Teknova, Inc. (NASDAQ:TKNO) news
Alpha Teknova, Inc. news releases on 6ix. Latest, Oct 2, 2026: Teknova and Pluristyx Announce FDA Drug Master File for the PluriFreeze™ Cryopreservation System
Press releases & updates
Teknova and Pluristyx Announce FDA Drug Master File for the PluriFreeze™ Cryopreservation System
October 2, 2026
Teknova Expands Custom Manufacturing with Fill-Tek™ Dispensing System for Flexible Single-Use Bag Filling
September 16, 2026
Teknova Reports Second Quarter 2026 Financial Results
August 5, 2026
Teknova to Report Second Quarter 2026 Financial Results on August 5, 2026
July 22, 2026
Alpha Teknova : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)
May 7, 2026
Teknova Reports First Quarter 2026 Financial Results
May 6, 2026
Teknova to Report First Quarter 2026 Financial Results on May 6, 2026
April 22, 2026
Teknova Reports Fourth Quarter and Full Year 2025 Financial Results
February 25, 2026
Teknova to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 5, 2026
Teknova Reports Third Quarter 2025 Financial Results
November 6, 2025
Teknova to Report Third Quarter 2025 Financial Results on November 6, 2025
October 28, 2025
Teknova Reports Second Quarter 2025 Financial Results
August 7, 2025
Teknova to Report Second Quarter 2025 Financial Results on August 7, 2025
July 24, 2025
Teknova Reports First Quarter 2025 Financial Results
May 8, 2025
Teknova to Report First Quarter 2025 Financial Results on May 8, 2025
April 24, 2025
Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies
March 19, 2025
Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies
March 11, 2025
Teknova Reports Fourth Quarter and Full Year 2024 Financial Results
March 4, 2025
Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
February 20, 2025
Teknova Reports Third Quarter 2024 Financial Results
November 6, 2024
Teknova to Report Third Quarter 2024 Financial Results on November 7, 2024
October 23, 2024
Teknova Reports Second Quarter 2024 Financial Results
August 12, 2024
Teknova Introduces Proprietary Express-Tek℠ Production Service and Expanded Manufacturing Grade Options to Expedite Novel Therapy Development
August 12, 2024
Teknova to Report Second Quarter 2024 Financial Results on August 13, 2024
July 29, 2024
Teknova Announces $15.4 Million Private Placement
July 10, 2024
Teknova Provides Strategic Business Update and Announces Preliminary Second Quarter 2024 Results
July 8, 2024
Teknova Reports First Quarter 2024 Financial Results
May 12, 2024
Teknova Launches Proprietary Build-Tek™ Solutions Custom Configurator and Latest AAV-Tek™ Product to Further Accelerate Novel Therapy Development
May 6, 2024
Teknova to Report First Quarter 2024 Financial Results on May 13, 2024
April 28, 2024
Teknova Reports Fourth Quarter and Full Year 2023 Financial Results
March 10, 2024
Teknova to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
February 20, 2024
Teknova Reports Third Quarter 2023 Financial Results
November 8, 2023
Teknova to Report Third Quarter 2023 Financial Results on November 9, 2023
October 25, 2023
Teknova Launches Latest Proprietary AAV-Tek™ Product and End-to-End Plasmid Workflow Solutions to Streamline Therapeutic Process Development
September 26, 2023
Teknova Announces Closing of $22.9 Million Concurrent Registered Direct Offering and Private Placement and Amends Credit Facility
September 18, 2023
Teknova Announces Up to $22.9 Million Concurrent Registered Direct Offering and Private Placement
September 17, 2023
Teknova Announces New Board Member, Martha J. Demski
August 15, 2023
Teknova Reports Second Quarter 2023 Financial Results
August 9, 2023
Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents
August 8, 2023
Teknova to Report Second Quarter 2023 Financial Results on August 10, 2023
July 25, 2023
Teknova and Sartorius BIA Separations Share Data Demonstrating Reliable and Scalable Approach for the Enhancement of AAV Full Capsid Enrichment with an Optimized AEX Platform
July 19, 2023
Teknova Expands Proprietary AAV-Tek™ Solutions Product Line to Deliver End-to-End Solutions for Gene Therapy Process Development
July 10, 2023
Teknova to Participate in Upcoming Investor Conference
May 24, 2023
Teknova to Present Data on Novel Products to Accelerate the Development of AAV Therapies at ASGCT 2023 Annual Meeting
May 9, 2023
Teknova Reports First Quarter 2023 Financial Results
May 9, 2023
Teknova Announces Time Change for First Quarter 2023 Financial Results Conference Call on May 10, 2023
May 3, 2023
Teknova Launches Proprietary AAV-Tek™ Solutions Gene Therapy Product Line to Accelerate the Development of AAV Therapies
May 1, 2023
Teknova to Report First Quarter 2023 Financial Results on May 10, 2023
April 25, 2023
Teknova Reports Fourth Quarter and Full Year 2022 Financial Results
March 14, 2023
Teknova and Sartorius BIA Separations Announce Collaboration to Address Critical Pain Point in Gene Therapy Process Development
March 14, 2023